| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
BRIEF REVIEWS |
Deeley Research Centre, British Columbia Cancer Agency, Victoria, British Columbia, Canada
IL-2 is a potent T cell growth factor that for many years was assumed to amplify lymphocyte responses in vivo. Accordingly, IL-2 has been used clinically to enhance T cell immunity in patients with AIDS or cancer, and blocking Abs to the IL-2R are used to inhibit T cell responses against transplanted tissues. It was later shown in mice that, unexpectedly, disruption of the IL-2 pathway results in lymphoid hyperplasia and autoimmunity rather than immune deficiency, indicating that the major physiological function of IL-2 is to limit rather than enhance T cell responses. This apparent paradox has recently been resolved with the discovery that IL-2 is critical for the development and peripheral expansion of CD4+CD25+ regulatory T cells, which promote self-tolerance by suppressing T cell responses in vivo. Our new understanding of IL-2 biology prompts a re-evaluation of how best to clinically manipulate this important immunoregulatory pathway.
This article has been cited by other articles:
|
|
 |
|
  K. Tsuji-Takayama, M. Suzuki, M. Yamamoto, A. Harashima, A. Okochi, T. Otani, T. Inoue, A. Sugimoto, T. Toraya, M. Takeuchi, et al. The Production of IL-10 by Human Regulatory T Cells Is Enhanced by IL-2 through a STAT5-Responsive Intronic Enhancer in the IL-10 Locus J. Immunol., September 15, 2008; 181(6): 3897 - 3905. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. McKarns and R. H. Schwartz Biphasic Regulation of Il2 Transcription in CD4+ T Cells: Roles for TNF-{alpha} Receptor Signaling and Chromatin Structure J. Immunol., July 15, 2008; 181(2): 1272 - 1281. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Ichiyama, H. Yoshida, Y. Wakabayashi, T. Chinen, K. Saeki, M. Nakaya, G. Takaesu, S. Hori, A. Yoshimura, and T. Kobayashi Foxp3 Inhibits ROR{gamma}t-mediated IL-17A mRNA Transcription through Direct Interaction with ROR{gamma}t J. Biol. Chem., June 20, 2008; 283(25): 17003 - 17008. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Takaki, K. Ichiyama, K. Koga, T. Chinen, G. Takaesu, Y. Sugiyama, S. Kato, A. Yoshimura, and T. Kobayashi STAT6 Inhibits TGF-{beta}1-mediated Foxp3 Induction through Direct Binding to the Foxp3 Promoter, Which Is Reverted by Retinoic Acid Receptor J. Biol. Chem., May 30, 2008; 283(22): 14955 - 14962. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. I. Lobo, K. H. Schlegel, C. E. Spencer, M. D. Okusa, C. Chisholm, N. Mchedlishvili, A. Park, C. Christ, and C. Burtner Naturally Occurring IgM Anti-Leukocyte Autoantibodies (IgM-ALA) Inhibit T Cell Activation and Chemotaxis J. Immunol., February 1, 2008; 180(3): 1780 - 1791. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. K. Selvaraj and T. L. Geiger A Kinetic and Dynamic Analysis of Foxp3 Induced in T Cells by TGF-beta J. Immunol., June 15, 2007; 178(12): 7667 - 7677. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Yao, Y. Kanno, M. Kerenyi, G. Stephens, L. Durant, W. T. Watford, A. Laurence, G. W. Robinson, E. M. Shevach, R. Moriggl, et al. Nonredundant roles for Stat5a/b in directly regulating Foxp3 Blood, May 15, 2007; 109(10): 4368 - 4375. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Bayer, A. Yu, and T. R. Malek Function of the IL-2R for Thymic and Peripheral CD4+CD25+ Foxp3+ T Regulatory Cells J. Immunol., April 1, 2007; 178(7): 4062 - 4071. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Matsubara, K. Takeda, T. Kodama, A. Joetham, N. Miyahara, T. Koya, C. H. Swasey, M. Okamoto, A. Dakhama, and E. W. Gelfand IL-2 and IL-18 Attenuation of Airway Hyperresponsiveness Requires STAT4, IFN-{gamma}, and Natural Killer Cells Am. J. Respir. Cell Mol. Biol., March 1, 2007; 36(3): 324 - 332. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. G. Zheng, J. Wang, P. Wang, J. D. Gray, and D. A. Horwitz IL-2 Is Essential for TGF-beta to Convert Naive CD4+CD25- Cells to CD25+Foxp3+ Regulatory T Cells and for Expansion of These Cells J. Immunol., February 15, 2007; 178(4): 2018 - 2027. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Lohr, B. Knoechel, J. J. Wang, A. V. Villarino, and A. K. Abbas Role of IL-17 and regulatory T lymphocytes in a systemic autoimmune disease J. Exp. Med., December 25, 2006; 203(13): 2785 - 2791. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. R. M. Almeida, B. Zaragoza, and A. A. Freitas Competition controls the rate of transition between the peripheral pools of CD4+CD25- and CD4+CD25+ T cells Int. Immunol., November 1, 2006; 18(11): 1607 - 1613. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Pejawar-Gaddy and M. A. Alexander-Miller Ligation of CD80 Is Critical for High-Level CD25 Expression on CD8+ T Lymphocytes J. Immunol., October 1, 2006; 177(7): 4495 - 4502. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Sato, H. Sanjo, T. Tsujimura, J. Ninomiya-Tsuji, M. Yamamoto, T. Kawai, O. Takeuchi, and S. Akira TAK1 is indispensable for development of T cells and prevention of colitis by the generation of regulatory T cells Int. Immunol., October 1, 2006; 18(10): 1405 - 1411. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. P. Lawrence, A. Kadioglu, A.-L. Yang, W. R. Coward, and S. C. Chow The Cathepsin B Inhibitor, z-FA-FMK, Inhibits Human T Cell Proliferation In Vitro and Modulates Host Response to Pneumococcal Infection In Vivo J. Immunol., September 15, 2006; 177(6): 3827 - 3836. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Toda and C. A. Piccirillo Development and function of naturally occurring CD4+CD25+ regulatory T cells J. Leukoc. Biol., September 1, 2006; 80(3): 458 - 470. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Zorn, E. A. Nelson, M. Mohseni, F. Porcheray, H. Kim, D. Litsa, R. Bellucci, E. Raderschall, C. Canning, R. J. Soiffer, et al. IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo Blood, September 1, 2006; 108(5): 1571 - 1579. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. T. Nardelli, T. F. Warner, S. M. Callister, and R. F. Schell Anti-CD25 Antibody Treatment of Mice Vaccinated and Challenged with Borrelia spp. Does Not Exacerbate Arthritis but Inhibits Borreliacidal Antibody Production. Clin. Vaccine Immunol., August 1, 2006; 13(8): 884 - 891. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. R. M. Almeida, B. Zaragoza, and A. A. Freitas Indexation as a Novel Mechanism of Lymphocyte Homeostasis: The Number of CD4+CD25+ Regulatory T Cells Is Indexed to the Number of IL-2-Producing Cells J. Immunol., July 1, 2006; 177(1): 192 - 200. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Huang, K. W. Kerstann, M. Ahmadzadeh, Y. F. Li, M. El-Gamil, S. A. Rosenberg, and P. F. Robbins Modulation by IL-2 of CD70 and CD27 Expression on CD8+ T Cells: Importance for the Therapeutic Effectiveness of Cell Transfer Immunotherapy. J. Immunol., June 15, 2006; 176(12): 7726 - 7735. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Frisancho-Kiss, J. F. Nyland, S. E. Davis, M. A. Barrett, S. J. L. Gatewood, D. B. Njoku, D. Cihakova, E. K. Silbergeld, N. R. Rose, and D. Fairweather Cutting Edge: T Cell Ig Mucin-3 Reduces Inflammatory Heart Disease by Increasing CTLA-4 during Innate Immunity. J. Immunol., June 1, 2006; 176(11): 6411 - 6415. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J Hayashi and O. Kanagawa Requirement of high-affinity IL-2-IL-2R interaction for T cell anergy induction Int. Immunol., May 1, 2006; 18(5): 645 - 651. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Antony, C. M. Paulos, M. Ahmadzadeh, A. Akpinarli, D. C. Palmer, N. Sato, A. Kaiser, C. Heinrichs, C. A. Klebanoff, Y. Tagaya, et al. Interleukin-2-Dependent Mechanisms of Tolerance and Immunity In Vivo J. Immunol., May 1, 2006; 176(9): 5255 - 5266. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Acres, M. Gantzer, C. Remy, N. Futin, N. Accart, O. Chaloin, J. Hoebeke, J.-M. Balloul, and S. Paul Fusokine Interleukin-2/Interleukin-18, a Novel Potent Innate and Adaptive Immune Stimulator with Decreased Toxicity Cancer Res., October 15, 2005; 65(20): 9536 - 9546. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Funatake, N. B. Marshall, L. B. Steppan, D. V. Mourich, and N. I. Kerkvliet Cutting Edge: Activation of the Aryl Hydrocarbon Receptor by 2,3,7,8-Tetrachlorodibenzo-p-dioxin Generates a Population of CD4+CD25+ Cells with Characteristics of Regulatory T Cells J. Immunol., October 1, 2005; 175(7): 4184 - 4188. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Salmena and R. Hakem Caspase-8 deficiency in T cells leads to a lethal lymphoinfiltrative immune disorder J. Exp. Med., September 19, 2005; 202(6): 727 - 732. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Baratelli, Y. Lin, L. Zhu, S.-C. Yang, N. Heuze-Vourc'h, G. Zeng, K. Reckamp, M. Dohadwala, S. Sharma, and S. M. Dubinett Prostaglandin E2 Induces FOXP3 Gene Expression and T Regulatory Cell Function in Human CD4+ T Cells J. Immunol., August 1, 2005; 175(3): 1483 - 1490. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Sharma, H. Bagavant, W. N. Jarjour, S.-S. J. Sung, and S.-T. Ju The Role of Fas in the Immune System Biology of IL-2R{alpha} Knockout Mice: Interplay among Regulatory T Cells, Inflammation, Hemopoiesis, and Apoptosis J. Immunol., August 1, 2005; 175(3): 1965 - 1973. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Cutolo and G J M Maestroni The melatonin-cytokine connection in rheumatoid arthritis Ann Rheum Dis, August 1, 2005; 64(8): 1109 - 1111. [Full Text] [PDF]
|
|
|
|
|
|
M. J. Robertson, H.-C. Chang, D. Pelloso, and M. H. Kaplan Impaired interferon-{gamma} production as a consequence of STAT4 deficiency after autologous hematopoietic stem cell transplantation for lymphoma Blood, August 1, 2005; 106(3): 963 - 970. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Marchetti, F. Franzetti, and A. Gori Partial immune reconstitution following highly active antiretroviral therapy: can adjuvant interleukin-2 fill the gap? J. Antimicrob. Chemother., April 1, 2005; 55(4): 401 - 409. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Antony, C. A. Piccirillo, A. Akpinarli, S. E. Finkelstein, P. J. Speiss, D. R. Surman, D. C. Palmer, C.-C. Chan, C. A. Klebanoff, W. W. Overwijk, et al. CD8+ T Cell Immunity Against a Tumor/Self-Antigen Is Augmented by CD4+ T Helper Cells and Hindered by Naturally Occurring T Regulatory Cells J. Immunol., March 1, 2005; 174(5): 2591 - 2601. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Liu, Q. Liu, H. Hamed, R. M. Anthony, A. Foster, F. D. Finkelman, J. F. Urban Jr, and W. C. Gause IL-2 and Autocrine IL-4 Drive the In Vivo Development of Antigen-Specific Th2 T Cells Elicited by Nematode Parasites J. Immunol., February 15, 2005; 174(4): 2242 - 2249. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Kinter, M. Hennessey, A. Bell, S. Kern, Y. Lin, M. Daucher, M. Planta, M. McGlaughlin, R. Jackson, S. F. Ziegler, et al. CD25+CD4+ Regulatory T Cells from the Peripheral Blood of Asymptomatic HIV-infected Individuals Regulate CD4+ and CD8+ HIV-specific T Cell Immune Responses In Vitro and Are Associated with Favorable Clinical Markers of Disease Status J. Exp. Med., August 2, 2004; 200(3): 331 - 343. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
